Indivior Pharmaceuticals, Inc 20-F for FY2023
Indivior Pharmaceuticals, Inc. (INDV)
20-F
2024-03-06
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 20-F
Indivior Pharmaceuticals, Inc filed this 20-F on March 6, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.09B
- up 21.3% from $901M a year earlier
- Net income
- $2M
- compared with a net loss of $53M a year earlier